PHARMA NORD EXPORT ApS: Financial statements 2020
CVR: 70996510
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
PHARMA NORD EXPORT ApS (CVR 70996510) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 2,167,135 and a net result of DKK 2,689,100 compared with DKK -582,561 the year before. That is an increase of 10.9% compared with the year before. Equity in the 2020 report amounted to DKK 40,767,667. The solvency ratio was 54.6%. The company had 48 employees in the financial year.
- Gross Profit
- DKK 2,167,135
- Profit/Loss
- DKK 2,689,100
- Equity
- DKK 40,767,667
- Total Assets
- DKK 74,675,475
- Employees
- 48
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 2.2 mio. | 2.7 mio. | 40.8 mio. | 48 |
| 2019 | - | 2 mio. | -583 t. | 73.1 mio. | - |
| 2018 | - | 2.1 mio. | 4.3 mio. | 69.8 mio. | - |
| 2017 | - | 1.9 mio. | 3.5 mio. | 65.5 mio. | - |
| 2016 | - | 2.2 mio. | 2.7 mio. | 62 mio. | - |
Official annual report
How creditworthy is PHARMA NORD EXPORT ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of December 14, 2020, Sven Moesgaard has stepped down as director of PHARMA NORD EXPORT ApS.
PHARMA NORD EXPORT ApS has published its annual report for 2019. Gross profit came to DKK 1,953,365, and the net result was DKK -582,561.
As of May 29, 2020, Eli Wallin is registered as adm. dir. of PHARMA NORD EXPORT ApS.
As of May 28, 2020, Eli Wallin has stepped down as director of PHARMA NORD EXPORT ApS.
As of January 28, 2020, PharmCo III ApS is registered as an owner of PHARMA NORD EXPORT ApS with an ownership share of 33%.
About PHARMA NORD EXPORT ApS
PHARMA NORD EXPORT ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 1982. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Eli Wallin. The board consists of Michael Christiani Havemann (chair) and Eli Wallin. The company is owned by PHARMCO II ApS and PharmCo III ApS. According to the 2025 annual report, the company had an average of 66 employees. In 2025, the company reported a gross profit of DKK 1,575,000 and a net result of DKK 11,516,000 compared with DKK 6,889,205 the year before. Equity in the 2025 report amounted to DKK 46,928,000.